In this issue of the World Journal for Pediatric and Congenital Heart Surgery, Calderon-Colmenero and colleagues describe the efforts of the Mexican Association of Specialists in Congenital Heart Disease to improve the quality of care for children with congenital heart disease in Mexico. 1 Their approach consisted of creating a national survey to assess existing resources, using this information to improve access to care while continuing to support highly specialized care for the most complex cases at regional centers, and creating a database to allow capture of uniform procedural and outcomes data.
These investigators have modeled their approach toward better understanding of the current spectrum of care and outcomes following congenital heart surgery in Mexico after that proposed by the World Society for Pediatric and Congenital Heart Surgery. 2 The proposal described several important tenets, including the use of common nomenclature and shared fundamental fields and data specifications in order to facilitate sharing and translation of information across the databases. RENACCAPE, the Mexican database, was created using similar terminology and definitions of those used in the Society of Thoracic Surgeons (STS) Congenital Heart Surgery Database, the European Association for Cardio-Thoracic Surgery (EACTS) Database, and the Japan Congenital Cardiovascular Surgery Database (JCCVSD), which are based on the International Pediatric and Congenital Cardiac Code.
The information collected in these clinical registries has improved our understanding of the operations performed to treat pediatric and congenital heart disease, and associated outcomes, through several mechanisms. 3 First, it has allowed a more in-depth understanding, on a national and international level, of the spectrum and type of operations performed. The data collected have also been used to define ''real-world'' outcomes for many congenital heart operations and have led to a better understanding of the variation in outcomes across the centers. Large multicenter data sets are well suited to these types of analyses, particularly for rare lesions for which each individual center may treat relatively few cases. In addition, series published in the literature often represent the experience of large centers with outstanding results and thus often do not give a complete picture regarding the full spectrum of outcomes. These large registry data sets have also served as a platform for the development of evidence-based risk adjustment systems, allowing empirical classification of the risk associated with certain procedures to facilitate more precise adjustment for differences in case mix across the centers. In addition, multicenter registries have also been used to study different patient factors and practices impacting outcomes. Through identifying areas of greatest variation in practice, and outcomes, these data sets can help to inform areas to target for future research.
However, beyond these aspects, likely the most important function served by these clinical registries is providing meaningful feedback to participating sites regarding their performance benchmarked to peer institutions and national averages. Without this, it is difficult for any institution to accurately evaluate its own performance. Although administrative data sets, which contain data collected from the hospital bill, may also provide this type of feedback to sites, these data sets can have significant limitations regarding capture of all relevant cases, coding and classification of operations performed, risk adjustment, and accounting for differences in case mix, all of which may impact accurate assessment of outcomes and performance.
Perhaps, the most valuable lesson learned from the Bristol inquiry in the United Kingdom is that the cardiac surgery units benefit from benchmarking their results in comparison to national and even international outcomes. This benchmarking is best accomplished through multi-institutional clinical databases. Such benchmarking may be particularly important in new programs, especially in the developing world. Several international clinical databases exist which track the outcomes of patients who undergo treatment for pediatric and congenital heart disease and facilitate benchmarking. The EACTS Congenital Heart Surgery Database captures data from multiple countries across Europe and has over 30 countries submitting data. The JCCVSD now contains data from over 25,000 pediatric cardiac operations in Japan and is engaged in dialog with other Asian countries to expand outside Japan. The STS Congenital Heart Surgery Database contains data from 105 of the 125 hospitals performing pediatric cardiac surgery in the United States (84% penetrance by hospital) and 3 of the 8 centers hospitals performing pediatric cardiac surgery in Canada. Although the STS Congenital Heart Surgery Database currently involves sites primarily located the United States and Canada, options are being explored to collaborate with centers in Mexico. In order to truly represent North America, participants outside the United States and Canada must be welcomed.
The geographical proximity of Mexico to the United States and Canada makes it logical to pursue collaboration between Mexican centers and the STS Congenital Heart Surgery Database. Similarly, centers in developing countries in Europe can collaborate with the EACTS Congenital Heart Surgery Database, and those in developing countries in Asia can collaborate with the JCCVSD. International activities of the STS Database span more than a decade and include collaborations with the EACTS, the Japan Adult Cardiovascular Surgery Database, the JCCVSD, and the Asian Society for Cardiovascular and Thoracic Surgery. 4 International expansion of the STS Database has generally focused on regions where no cardiothoracic registries currently exist, and it is the intention of the STS Database to collaborate with rather than compete with registries where they are currently in widespread use. The STS International Database Relations Task Force is currently in contact with over 20 international surgical centers. These programs have expressed interest in participating in the STS Database and receiving individual feedback reports benchmarked against the results from the US sites; some have also requested summaries of the program performance of their region or country.
The STS leadership believes that making the STS Database available to surgeons at centers in other countries will greatly enhance their ability to assess and improve quality and to conduct meaningful research, thus enhancing the care that cardiothoracic surgeons deliver worldwide. Countries where surgeons are currently participating in the STS Adult Cardiac Surgery Database include the United States (49 states), Brazil, Israel, and Turkey. Countries with surgeons participating in the STS Congenital Heart Surgery Database are the United States (39 states), Canada (three Canadian Provinces), and Japan.
Participating in a registry and receiving feedback information benchmarked to national data may in and of itself stimulate efforts in participating sites directed toward improving performance. However, this can also be challenging as it may not be clear where best to direct efforts to improve performance; and even if this is apparent, sites may have limited local infrastructure to facilitate translating this knowledge into changing practice.
Thus, it has been suggested that collaboratives focused on not only providing feedback to sites on performance but also evaluating and sharing information in a transparent fashion on differences in care and practices across sites, along with training local teams in quality improvement principals, may be the most effective way to use the information collected in clinical registries to drive improvements in the quality of care and outcomes. The Northern New England Cardiovascular Disease Study Group pioneered work in this area in the adult cardiac surgery population in the 1980s. 5 Using these principals, this group was able to hone in on the reasons for variation in mortality rates in patients undergoing coronary artery bypass grafting across hospitals and subsequently design targeted initiatives that were able to significantly improve the survival of these patients and reduce variation in outcomes across the centers. Subsequently, many other groups have successfully adopted this methodology. For example, hospitals participating in the Michigan Surgical Quality Collaborative have significantly lowered their risk-adjusted mortality rates over time following general and vascular surgery to a greater extent compared to hospitals submitting data to a registry alone. 6 Moreover, these efforts have also been shown to reduce health care expenditures in addition to improving outcomes, which is of particular importance in this era of rising health care costs.
In congenital heart surgery, efforts are underway within groups such as the STS, Pediatric Cardiac Critical Care Consortium, the Joint Council on Congenital Heart Disease, and the National Heart, Lung, and Blood Institute-sponsored Pediatric Heart Network to leverage the wealth of data now available in multicenter registries and collaboratives to drive quality improvement based on the principals described above. Rigorous collection of meaningful data in order to inform best practices has been shown to be a critical first step, and the Mexican Association of Specialists in Congenital Heart Disease should be commended for taking this important step toward improving the quality of care in children with congenital heart disease in Mexico. Future collaborative efforts between the RENACCAPE (the Mexican database) and the STS Congenital Heart Surgery Database may further facilitate this objective. This expanded database could further enhance and support the outcomes analysis and quality improvement in patients with pediatric and congenital cardiac disease across North America.
